Judith Z Goldfinger1, Liliana R Preiss2, Richard B Devereux3, Mary J Roman3, Tabitha P Hendershot2, Barbara L Kroner2, Kim A Eagle4. 1. Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: judith.goldfinger@mountsinai.org. 2. Biostatistics and Epidemiology Division, Research Triangle Institute International, Rockville, Maryland. 3. Division of Cardiology, Weill Cornell Medical College, New York, New York. 4. Department of Cardiology, University of Michigan Health System, Ann Arbor, Michigan.
Abstract
BACKGROUND: Previous small studies suggested reduced quality of life (QOL) for people with Marfan syndrome (MFS) compared with those without MFS. The national registry of GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) is a longitudinal observational cohort study of patients with conditions that predispose to thoracic aortic aneurysms and dissections, including MFS. At the time of registry enrollment, GenTAC study participants are asked to complete questionnaires about demographics, medical history, health habits, and QOL. OBJECTIVES: This study assessed QOL in GenTAC participants with MFS and identify associated factors using self-reported data. METHODS: QOL was assessed using the 4 subscales of the Physical Component Summary (PCS) of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36): physical functioning; role limitations due to physical health; bodily pain; and general health. We studied the association of QOL with self-reported demographics, health behaviors, physical impairments, surgeries, comorbid medical conditions, medications, and MFS severity. RESULTS: In the GenTAC registry, 389 adults with MFS completed the SF-36. Mean age was 41 years, 51% were men, 92% were white, and 65% were college graduates. The mean PCS composite score was 42.3. In bivariate analysis, predictors of better QOL included college education, marital status, higher household income, private health insurance, full-time employment, moderate alcohol use, fewer prior surgeries, fewer comorbid conditions, absence of depression, and less severe MFS manifestations. In a multivariable analysis, insurance status and employment remained significant predictors of QOL. CONCLUSIONS: In a large cohort of patients with MFS in the GenTAC registry, health-related QOL was below the population norm. Better QOL was independently associated with socioeconomic factors, not factors related to general health or MFS severity.
BACKGROUND: Previous small studies suggested reduced quality of life (QOL) for people with Marfan syndrome (MFS) compared with those without MFS. The national registry of GenTAC (Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions) is a longitudinal observational cohort study of patients with conditions that predispose to thoracic aortic aneurysms and dissections, including MFS. At the time of registry enrollment, GenTAC study participants are asked to complete questionnaires about demographics, medical history, health habits, and QOL. OBJECTIVES: This study assessed QOL in GenTACparticipants with MFS and identify associated factors using self-reported data. METHODS: QOL was assessed using the 4 subscales of the Physical Component Summary (PCS) of the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36): physical functioning; role limitations due to physical health; bodily pain; and general health. We studied the association of QOL with self-reported demographics, health behaviors, physical impairments, surgeries, comorbid medical conditions, medications, and MFS severity. RESULTS: In the GenTAC registry, 389 adults with MFS completed the SF-36. Mean age was 41 years, 51% were men, 92% were white, and 65% were college graduates. The mean PCS composite score was 42.3. In bivariate analysis, predictors of better QOL included college education, marital status, higher household income, private health insurance, full-time employment, moderate alcohol use, fewer prior surgeries, fewer comorbid conditions, absence of depression, and less severe MFS manifestations. In a multivariable analysis, insurance status and employment remained significant predictors of QOL. CONCLUSIONS: In a large cohort of patients with MFS in the GenTAC registry, health-related QOL was below the population norm. Better QOL was independently associated with socioeconomic factors, not factors related to general health or MFS severity.
Authors: Michiel M Winter; Claire Reisma; Harald Kedde; Berto J Bouma; Jeroen C Vis; Paul Luijendijk; Piet de Witte; Aielko H Zwinderman; Hubert W Vliegen; Petronella G Pieper; Arie P J van Dijk; Barbara J M Mulder Journal: Am J Cardiol Date: 2010-10-15 Impact factor: 2.778
Authors: N K Aaronson; M Muller; P D Cohen; M L Essink-Bot; M Fekkes; R Sanderman; M A Sprangers; A te Velde; E Verrips Journal: J Clin Epidemiol Date: 1998-11 Impact factor: 6.437
Authors: Suzanne K Chambers; Xingqiong Meng; Pip Youl; Joanne Aitken; Jeff Dunn; Peter Baade Journal: Qual Life Res Date: 2011-12-27 Impact factor: 4.147
Authors: Kathryn W Holmes; Cheryl L Maslen; Mark Kindem; Barbara L Kroner; Howard K Song; William Ravekes; H C Dietz; Jonathan W Weinsaft; Mary J Roman; Richard B Devereux; Reed E Pyeritz; Joseph Bavaria; Karianna Milewski; Dianna Milewicz; Scott A LeMaire; Tabitha Hendershot; Kim A Eagle; H Eser Tolunay; Patrice Desvigne-Nickens; Michael Silberbach Journal: Am J Med Genet A Date: 2013-02-26 Impact factor: 2.802
Authors: Natalia Sadetsky; Deborah P Lubeck; David J Pasta; David M Latini; Janeen DuChane; Peter R Carroll Journal: BJU Int Date: 2008-03 Impact factor: 5.588
Authors: Jill C Handisides; Danielle Hollenbeck-Pringle; Karen Uzark; Felicia L Trachtenberg; Victoria L Pemberton; Teresa W Atz; Timothy J Bradley; Elizabeth Cappella; Sylvia De Nobele; Georgeann Keh-Teng Groh; Michelle S Hamstra; Rosalind Korsin; Jami C Levine; Bergen Lindauer; Aimee Liou; Meghan K Mac Neal; Larry W Markham; Tonia Morrison; Kathleen A Mussatto; Aaron K Olson; Mary Ella M Pierpont; Reed E Pyeritz; Elizabeth A Radojewski; Mary J Roman; Mingfen Xu; Ronald V Lacro Journal: J Pediatr Date: 2018-09-27 Impact factor: 4.406
Authors: Dianna M Milewicz; Alan C Braverman; Julie De Backer; Shaine A Morris; Catherine Boileau; Irene H Maumenee; Guillaume Jondeau; Arturo Evangelista; Reed E Pyeritz Journal: Nat Rev Dis Primers Date: 2021-09-02 Impact factor: 65.038
Authors: Allard T van den Hoven; Lidia R Bons; Ramon H M Dykgraaf; Arianne B Dessens; Hester Pastoor; Laura C G de Graaff; Mick R Metselaar; Annemiek Kneppers-Swets; Isabella Kardys; Hester Mijnarends; Frank Zweerus; Jan A Hazelzet; Elisabeth M W J Utens; Annemien E van den Bosch; Jolien W Roos-Hesselink Journal: Clin Endocrinol (Oxf) Date: 2020-02-18 Impact factor: 3.478
Authors: Lidia R Bons; Allard T van den Hoven; Ayda E Damirchi; Denise van der Linde; Silvy Dekker; Robert M Kauling; Ingrid M B H van de Laar; Elisabeth M W J Utens; Ricardo P J Budde; Jolien W Roos-Hesselink Journal: Am J Med Genet A Date: 2019-05-27 Impact factor: 2.802
Authors: Carlijn G E Thijssen; Daphne E Doze; Arjen L Gökalp; Janneke Timmermans; Jeannette B Peters; Laura H C Elbers-van de Ven; Niels van Royen; Johanna J M Takkenberg; Jolien W Roos-Hesselink; Roland R J van Kimmenade Journal: J Genet Couns Date: 2020-06-10 Impact factor: 2.537